1,256
Views
5
CrossRef citations to date
0
Altmetric
Empirical Studies

Patients’ experiences of changes in health complaints before, during, and after removal of dental amalgam

(PhD student) , (Professor) , (Senior Researcher) , (Senior Executive Officer) , , Dr Philos & (Principal Researcher)
Article: 28157 | Accepted 25 May 2015, Published online: 24 Jun 2015

References

  • Binder P.-E., Holgersen H., Moltu C. Staying close and reflexive: An explorative and reflexive approach to qualitative research on psychotherapy. Nordic Psychology. 2012; 64(2): 103–117.
  • Braun V., Clarke V. Using thematic analysis in psychology. Qualitative Research in Psychology. 2006; 3(2): 77–101. doi: 10.1191/1478088706qp063oa.
  • Cassell E. J. The nature of suffering and the goals of medicine. New England Journal of Medicine. 1982; 306(11): 639–645. doi: 10.1056/nejm198203183061104.
  • Clarkson T. W., Magos L., Myers G. J. The toxicology of mercury—Current exposures and clinical manifestations. New England Journal of Medicine. 2003; 349(18): 1731–1737. [PubMed Abstract] doi: 10.1056/NEJMra022471.
  • Dental Biomaterials Adverse Reaction Unit. Fjerning av amalgamfyllinger [Removal of amalgam restorations]. Den Norske Tannnlegeforenings Tidende. 2002; 112(1): 50–51.
  • Denzin N. K. Interpretive interactionism. 2001; 2nd ed., Thousand Oaks: Sage.
  • Geertz C. The interpretation of cultures: Selected essays. 1973; New York: Basic Books.
  • Issa Y., Brunton P. A., Glenny A. M., Duxbury A. J. Healing of oral lichenoid lesions after replacing amalgam restorations: A systematic review. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. 2004; 98(5): 553–565. [PubMed Abstract] doi: 10.1016/j.tripleo.2003.12.027.
  • Jones L. M. Focus on fillings: A qualitative health study of people medically diagnosed with mercury poisoning, linked to dental amalgam. Acta Neuropsychiatrica. 2004; 16(3): 142–148. doi: 10.1111/j.0924-2708.2004.00069.x.
  • Jutel A. Medically unexplained symptoms and the disease label. Social Theory and Health. 2010; 8(3): 229–245. doi: 10.1057/sth.2009.21.
  • Kirmayer L. J. Improvisation and authority in illness meaning. Culture, Medicine and Psychiatry. 1994; 18(2): 183–214. [PubMed Abstract].
  • Kornelsen J., Atkins C., Brownell K., Woollard R. The meaning of patient experiences of medically unexplained physical symptoms. Qualitative Health Research. 2015. doi: 10.1177/1049732314566326.
  • Langworth S., Björkman L., Elinder C. G., Järup L., Savlin P. Multidisciplinary examination of patients with illness attributed to dental fillings. Journal of Oral Rehabilitation. 2002; 29(8): 705–713. [PubMed Abstract] doi: 10.1046/j.1365-2842.2002.00963.x.
  • Loeser J. D. Pain and suffering. The Clinical Journal of Pain. 2000; 16(2 Suppl.): S2–6. [PubMed Abstract].
  • Lygre G. B., Gjerdet N. R., Björkman L. Patients’ choice of dental treatment following examination at a specialty unit for adverse reactions to dental materials. Acta Odontologica Scandinavica. 2004; 62(5): 258–263. [PubMed Abstract] doi: 10.1080/00016350410001694.
  • Lygre G. B., Gjerdet N. R., Björkman L. A follow-up study of patients with subjective symptoms related to dental materials. Community Dentistry and Oral Epidemiology. 2005; 33(3): 227–234. [PubMed Abstract] doi: 10.1111/j.1600-0528.2005.00223.x.
  • Madden S., Sim J. Creating meaning in fibromyalgia syndrome. Social Science and Medicine. 2006; 63(11): 2962–2973. [PubMed Abstract] doi: 10.1016/j.socscimed.2006.06.020.
  • Melchart D., Vogt S., Kohler W., Streng A., Weidenhammer W., Kremers L. Treatment of health complaints attributed to amalgam. Journal of Dental Research. 2008; 87(4): 349–353. [PubMed Abstract] doi: 10.1177/154405910808700410.
  • Needleman H. L. Mercury in dental amalgam—A neurotoxic risk?. JAMA. 2006; 295(15): 1835–1836. [PubMed Abstract] doi: 10.1001/jama.295.15.1835.
  • Nerdrum P., Malt U. F., Hoglend P., Oppedal B., Gundersen R., Holte M. A 7-year prospective quasi-experimental study of the effects of removing dental amalgam in 76 self-referred patients compared with 146 controls. Journal of Psychosomatic Research. 2004; 57(1): 103–111. [PubMed Abstract] doi: 10.1016/s0022-3999(03)00542-7.
  • Norwegian Directorate of Health. Nasjonale retningslinjer for utredning og behandling ved mistanke om bivirkninger fra odontologiske biomaterialer [National guidelines for clinical examination and treatment of suspected adverse reactions to dental biomaterials]. 2008; Oslo: Norwegian Directorate of Health.
  • Ponterotto J. G. Brief note on the origins, evolution, and meaning for the qualitative research concept “thick description”. The Qualitative Report. 2006; 11(3): 538–549.
  • QSR International Pty Ltd. NVivo qualitative data analysis software (Version 9). 2010. Retrieved June 13, 2015, from www.qsrinternational.com/products_previous-products_nvivo9.aspx.
  • Richardson G. M., Wilson R., Allard D., Purtill C., Douma S., Gravière J. Mercury exposure and risks from dental amalgam in the US population, post-2000. Science of the Total Environment. 2011; 409(20): 4257–4268. [PubMed Abstract] doi: 10.1016/j.scitotenv.2011.06.035.
  • Sjursen T. T., Binder P.-E., Lygre G. B., Helland V., Dalen K., Björkman L. How unexplained health complaints were attributed to dental amalgam. Nordic Psychology. 2014; 66(3): 216–229. doi: 10.1080/19012276.2014.964958.
  • Sjursen T. T., Lygre G. B., Dalen K., Helland V., Laegreid T., Svahn J. Changes in health complaints after removal of amalgam fillings. Journal of Oral Rehabilitation. 2011; 38(11): 835–848. [PubMed Abstract] [PubMed CentralFull Text] doi: 10.1111/j.1365-2842.2011.02223.x.
  • Stahlnacke K., Soderfeldt B. An interview study of persons who attribute health problems to dental filling materials—Part two in a triangulation study on 65 and 75 years old Swedes. Swedish Dental Journal. 2013; 37(3): 121–130. [PubMed Abstract].
  • Tillberg A., Berglund A., Marell L., Bergdahl J., Eriksson N., Linden G. Changes in health over time in patients with symptoms allegedly caused by their dental restorative materials. Community Dentistry and Oral Epidemiology. 2005; 33(6): 427–437. [PubMed Abstract] doi: 10.1111/j.1600-0528.2005.00240.x.
  • US Food and Drug Administration. Dental devices: Classification of dental amalgam, reclassification of dental mercury, designation of special controls for dental amalgam, mercury and amalgam alloy. Final rule. Federal Register. 2009; 74(148): 38685–714.
  • Vamnes J. S., Lygre G. B., Grönningsæter A. G., Gjerdet N. R. Four years of clinical experience with an adverse reaction unit for dental biomaterials. Community Dentistry and Oral Epidemiology. 2004; 32(2): 150–157. [PubMed Abstract] doi: 10.1111/j.0301-5661.2004.00148.x.